PREDNISOLONE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C21H28O5
Molecular Weight	360.444
Optical Activity	UNSPECIFIED
Defined Stereocenters	7 / 7
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of PREDNISOLONE

Structure Search

SMILES

[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]3([H])[C@@]2([H])CCC4=CC(=O)C=C[C@]34C

InChI

InChIKey=OIGNJSKKLXVSLS-VWUMJDOOSA-N

InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C21H28O5
Molecular Weight	360.444
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	7 / 7
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:14:38 UTC 2023` Edited by `admin` on `Fri Dec 15 15:14:38 UTC 2023`
Record UNII	9PHQ9Y1OLM
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PREDNISOLONE

Official Name

English

CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE

Common Name

English

METI-DERM

Brand Name

English

NSC-9120

Code

English

METHYLPREDNISOLONE IMPURITY K [EP IMPURITY]

Common Name

English

NSC-9900

Code

English

11.BETA.,17,21-TRIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE.

Common Name

English

11β,17,21-Trihydroxypregna-1,4-diene-3,20-dione

Systematic Name

English

PREDNISOLONE (EMA EPAR: VETERINARY)

Common Name

English

PREDNISOLONE [MART.]

Common Name

English

PREDNISOLONE COMPONENT OF CHLOROPTIC-P S.O.P.

Common Name

English

(+)-PREDNISOLONE

Common Name

English

PREDNISOLONE [ORANGE BOOK]

Common Name

English

PREDNISONE IMPURITY B [EP]

Common Name

English

PREDNISOLONE ANHYDROUS

Common Name

English

DELTAHYDROCORTISONE

Common Name

English

APREDNISLON

Common Name

English

PREDNISOLONE [EP]

Common Name

English

PREDNICARBATE IMPURITY A [EP IMPURITY]

Common Name

English

Prednisolone [WHO-DD]

Common Name

English

DELTA-CORTEF

Brand Name

English

PREDNISOLONE [JAN]

Common Name

English

EQUISOLON

Brand Name

English

PREDNISOLONE [HSDB]

Common Name

English

PREDNISOLONE ACETATE IMPURITY B [EP IMPURITY]

Common Name

English

PANAFCORTELONE

Common Name

English

HYDRORETROCORTINE

Common Name

English

PREDNISOLONUM [WHO-IP LATIN]

Common Name

English

prednisolone [INN]

Common Name

English

CODELCORTONE

Common Name

English

FERNISOLONE-P

Brand Name

English

PREDNISOLONE [MI]

Common Name

English

PREDNISOLONE [EP MONOGRAPH]

Common Name

English

PREDNISOLONE [VANDF]

Common Name

English

PREDNISOLONE [USP-RS]

Common Name

English

PREDNISOLONE [GREEN BOOK]

Common Name

English

PREGNA-1,4-DIENE-3,20-DIONE, 11,17,21-TRIHYDROXY-, (11.BETA)-

Common Name

English

SUPERCORTISOL

Common Name

English

DELTACORTRIL

Brand Name

English

PREDNISOLONE [WHO-IP]

Common Name

English

PREDNISOLONE [USP MONOGRAPH]

Common Name

English

METACORTANDRALONE

Common Name

English

STERANE

Brand Name

English

VETSOLONE

Common Name

English

CORTALONE

Brand Name

English

HYDROCORTISONE IMPURITY A [EP IMPURITY]

Common Name

English

Classification Tree Code System Code

WHO-VATC

QS03CA02

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QS01CB02

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QA01AC54

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

NDF-RT

N0000175576

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

S01CA02

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

D07CA03

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

C05AA04

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

S01CB02

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

A01AC54

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

S02CA01

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QC05AA04

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

CFR

21 CFR 520.1880

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

NDF-RT

N0000175450

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

CFR

21 CFR 520.2604

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ESSENTIAL MEDICINES LIST

03

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QD07XA02

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QH02AB56

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QS02BA03

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

CFR

21 CFR 524.1484K

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

S01BB02

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

CFR

21 CFR 520.2345H

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

CFR

21 CFR 524.1484F

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

NCI_THESAURUS

C521

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

A07EA01

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QD07CA03

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

EMA VETERINARY ASSESSMENT REPORTS

EQUISOLON (AUTHORISED)

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

V03AB05

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QS01CA02

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

S03BA02

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

S01BA04

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QD07BA01

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

CFR

21 CFR 524.1445

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

R01AD52

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

H02AB06

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QS03BA02

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QS01BA04

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

S02BA03

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

R01AD02

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

D07AA03

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

D07BA01

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QR01AD52

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ESSENTIAL MEDICINES LIST

21.2

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QS02CA01

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ESSENTIAL MEDICINES LIST

8.3

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QR01AD02

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QD07AA03

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

S03CA02

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QV03AB05

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QH02AB06

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

CFR

21 CFR 520.2605

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-ATC

D07XA02

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QA07EA01

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

LIVERTOX

794

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

CFR

21 CFR 522.1885

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

CFR

21 CFR 524.1484J

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

WHO-VATC

QS01BB02

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

Code System Code Type Description

NSC

9900

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

DRUG CENTRAL

2245

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

MERCK INDEX

m9111

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

Merck Index

WIKIPEDIA

PREDNISOLONE

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

PUBCHEM

5755

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

EVMPD

SUB10018MIG

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

WHO INTERNATIONAL PHARMACOPEIA

PREDNISOLONE

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

Description: A white or almost white, crystalline powder; odourless. Solubility. Soluble in 1300 parts of water and in 30 parts of dehydrated ethanol R; soluble in methanol R and dioxan R. Category: Adrenocortical steroid. Storage: Prednisolone should be kept in a tightly closed container, protected from light. Additional information: Prednisolone is hygroscopic; it has a melting temperature of about 230?C with decomposition. Definition: Prednisolone contains not less than 97.0% and not more than 102.0% of C21H28O5, calculated with reference to thedried substance.

RXCUI

8638

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

RxNorm

FDA UNII

9PHQ9Y1OLM

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

NCI_THESAURUS

C769

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

RS_ITEM_NUM

1555005

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

EPA CompTox

DTXSID9021184

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

DAILYMED

9PHQ9Y1OLM

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

HSDB

3385

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

DRUG BANK

DB00860

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

INN

535

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

SMS_ID

100000091520

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

ChEMBL

CHEMBL131

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

CAS

50-24-8

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

IUPHAR

2866

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

MESH

D011239

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

CAS

8056-11-9

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

SUPERSEDED

ECHA (EC/EINECS)

200-021-7

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

NSC

9120

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

LACTMED

Prednisolone

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

CHEBI

8378

Created by admin on Fri Dec 15 15:14:38 UTC 2023 , Edited by admin on Fri Dec 15 15:14:38 UTC 2023

PRIMARY

Related Record Type Details


					FZW85LW99M

GLUCOCORTICOID RECEPTOR

TARGET -> AGONIST

Amount:


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Interaction Type:

BINDING

Amount:


					4937O9X01I

PREDNISOLONE SESQUIHYDRATE

SALT/SOLVATE -> PARENT

Amount:


					4937O9X01I

PREDNISOLONE SESQUIHYDRATE

SOLVATE->ANHYDROUS

Amount:


					ZIF514RVZR

BINDER->LIGAND

Comments:

BINDING LARGELY TO ALBUMIN; DOSAGE SHOULD BE REDUCED IN HYPOALBUMINANEMIA

Interaction Type:

BINDING

Amount:

Related Record Type Details


					SR3YX73FW2

PREDNISOLONE METAZOATE

PRODRUG -> METABOLITE ACTIVE

Amount:


					752SY38R6C

PREDNISOLONE 21-PHOSPHATE

PRODRUG -> METABOLITE ACTIVE

Amount:


					VB0R961HZT

PRODRUG -> METABOLITE ACTIVE

Amount:

Related Record Type Details


					NN79HDK6LV

(11β,20S)-11,17,20,21-Tetrahydroxypregna-1,4-dien-3-one

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					T89KRT8XVE

.DELTA.'-DEHYDROCORTEXOLONE

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:

8B2807733D

PREDNISOLONE ACETATE

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					MT32XMB69T

11.BETA.,14.ALPHA.,17,21-TETRAHYDROXYPREGNA-1,4-DIENE-3,20-DIONE

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					WI4X0X7BPJ

PARENT -> IMPURITY

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					V901LV1K7D

PARENT -> IMPURITY

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					WI4X0X7BPJ

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					X4W7ZR7023

METHYLPREDNISOLONE

PARENT -> IMPURITY

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:

8B2807733D

PREDNISOLONE ACETATE

PARENT -> IMPURITY

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					J280872D1O

DESONIDE

PARENT -> IMPURITY

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

USP

Amount:


					VB0R961HZT

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					VB0R961HZT

PARENT -> IMPURITY

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					VC7U8F7FXE

(11.ALPHA.)-11,17,21-TRIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					EEN45FVD9K

.DELTA.6-PREDNISOLONE

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					UT5TNW0Q0U

6.BETA.-HYDROXYPREDNISOLONE

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:


					FY7AZ5TJU4

(11.BETA.)-11,21-DIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE

IMPURITY -> PARENT

Interaction Type:

CHROMATOGRAPHIC PURITY (HPLC/UV)

Qualification:

EP

Amount:

Related Record Type Details


					9PHQ9Y1OLM

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Biological Half-life	PHARMACOKINETIC				Elimination PHARMACOKINETIC Elimination PHARMACOKINETIC